BioCentury
ARTICLE | Clinical News

Inovio preclinical data

December 17, 2012 8:00 AM UTC

In mice, Inovio's SynCon DNA HBV vaccine delivered with the company's electroporation system induced "strong" antigen-specific T cell and high titer antibody responses systemically and in the liver. I...